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Abstract
Oestrogen is a powerful mitogen that is believed to exert a
continuous, dose-dependent trophic stimulus at the anterior
pituitary. This persistent mitotic effect contrasts with
corticosterone and testosterone, changes in the levels of
which induce only transient, self-limiting ﬂuctuations in
pituitary mitotic activity. To further deﬁne the putative long-
term trophic effects of oestrogen, we have accurately analysed
the effects of 7 and 28 days oestrogen treatment on anterior
pituitary mitotic activity in ovariectomized 10-week-old
Wistar rats using both bromodeoxyuridine (BrdU) and timed
colchicine-induced mitotic arrest. An oestrogen dose-
dependent increase in mitotic index was seen 7 days after
the start of treatment as expected, representingan acceleration
in gross mitotic activity from 1.7%/day in ovariectomized
animals in the absence of any oestrogen replacement to
3.7%/day in the presence of a pharmacological dose of
oestrogen (50 mcg/rat per day: w230 mcg/kg per day).
Despite continued exposure to high-dose oestrogen and
persistence of the increase in pituitary wet weight, the
increase in mitotic index was unexpectedly not sustained.
After 28 days of high-dose oestrogen treatment, anterior
pituitary mitotic index and BrdU-labelling index were not
signiﬁcantly different from baseline. Although a powerful
pituitary mitogen in the short term, responsible, presumably,
for increased trophic variability in oestrus cycling females,
these data indicate that in keeping with other trophic stimuli
to the pituitary and in contrast to a much established dogma,
the mitotic response to longer-term high-dose oestrogen
exposure is transient and is not the driver of persistent
pituitary growth, at least in female Wistar rats.
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Introduction
The anterior pituitary, like many other endocrine tissues,
retains considerable plasticity throughout adult life. The
precise quantitative and qualitative nature of any pituitary
mitotic and/or apoptotic response is inﬂuenced by the nature
of the speciﬁc stimulus or stimuli, its amplitude, duration and
timing. As a trophic modulator, oestrogen is both quan-
titatively and qualitatively different to testosterone. Testoster-
one tonically inhibits pituitary mitotic activity and the
withdrawal of physiological levels in male animals results in a
self-limiting wave of increased pituitary mitosis lasting 2–3
weeks(Nolan&Levy2006).Testosteronereplacementduring
the period of increased mitosis that follows orchidectomy
rapidly restores mitotic activity to levels in intact animals
(Nolan & Levy 2006). Oestrogen, in contrast, is believed to
exert a potent and persistent rather than self-limiting
stimulatory effect on anterior pituitary mitotic activity. As a
result, pharmacological doses of oestrogen have been
implicated in both hyperplasia of pituitary lactotrophs and in
the induction and propagation of pituitary adenomas in the
longerterm.Otherobservationssuggestingapersistenttrophic
inﬂuence of oestrogen are that the pituitary is slightly larger in
human females than in males (Denk et al. 1999) and is larger
again in multiparous women (Chanson et al. 2001). Pituitary
size increases during human pregnancy by 15–36% and peaks
several days post partum (Dinc et al. 1998). In both humans and
rats, it has been reported that concomitant with this change in
pituitary size is a marked increase in lactotrophs from around
17% antenatally (Asa et al. 1982) to 50% at term (Haggi et al.
1986). If suckling does not take place, lactotroph mass returns
toalmostnormalwithin1–3weeks,butremainsslightlyhigher
after pregnancy than in nulliparous rats, implying that
pregnancy-induced changes in the size of the prolactin
immunopositive population are not entirely reversible (Asa
et al. 1982). It has also been assumed that different patterns of
physiologicaloestrogenexposure–stableatlowlevelsinmales
and ﬂuctuating at higher levels throughout reproductivelife in
females – are implicated in the sexually dimorphic charac-
teristics of prolactinomas described by some (Ma et al. 2002,
Nishioka et al. 2003, Delgrange et al. 2005, Schaller 2005) but
notallgroups(Calle-Rodrigueetal.1998)andintheincreased
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rats (Oishi et al. 1993, McNicol & Carbajo-Perez 1999).
A peak in anterior pituitary lactotroph mitotic activity has
frequently been shown to occur in oestrous, correlating with
the preceding increase in oestrogen levels during the pro-
oestrousphaseofthefemalereproductivecycle(Takahashietal.
1984, Oishi et al. 1993). Using bromodeoxyuridine (BrdU)-
labelling, it has been reported that increased proliferation seen
in the female rat pituitaryat oestrous occurs in lactotrophs and
requires central brain activity in the preceding pro-oestrous
afternoon (Hashi et al. 1995). No statistically signiﬁcant
increase in the proportion of lactotrophs was observed,
however, suggesting that either newly formed lactotrophs
undergo early apoptosis, that other cell types were similarly
inﬂuenced byoestrogenﬂuctuations leaving the proportion of
lactotrophs unchanged, or that the overall lactotroph increase
in each cyclewas too small to quantify (Hashi et al. 1995). The
latter would certainly be expected if sexually dimorphic
differences in pituitary size after puberty result from the
cumulative effects of small oestrogen-induced residual
increases in cell number or size following each oestrous
cycle. The assumption of a direct association between
oestrogen exposure and pituitary size, however, and dismissal
of a major contribution of oestrogen-responsive secretory cell
typesother thanlactotrophsmaybepremature.Indeed,oneof
the most marked sexually dimorphic differences in lactotroph
numbers is seen in female mice transgenic for high-level
expression of bovine GH (Vidal et al. 1999).
Oestrogen receptors, both a and b, are present in
subpopulations of rat pituitary cells, particularly lactotrophs
(50% express ERa and 30% express ERb) and a proportion of
folliculostellate cells (Mitchner et al. 1998), but are also found
in somatotrophs, thyrotrophs and gonadotrophs both during
development (Nishihara et al. 2000) and in adulthood
(Gonza ´lez et al. 2008). Oestrogen is implicated in the
stimulation of prolactin synthesis and secretion and prolifer-
ation of pituitary lactotrophs in humans and rodents. It has
been suggested that paracrine interactions between lacto-
trophs and folliculostellate cells might regulate the mitogenic
action of estradiol (Schwartz 2000, Oomizu et al. 2004),
although the necessity for such interactions has been disputed
(Ishida et al. 2007). In the longer-term oestrogen is thought to
be ultimately responsible for the induction of prolactinomas
in certain strains of rats such as male and female Fisher 344,
but in general, despite the latter and a few case reports
(Gooren et al. 1988, Garcia & Kapcala 1995), prolonged
exposure to supraphysiological doses of exogenous oestrogens
in humans does not inevitably result in either hyperprolacti-
naemia, pituitary hyperplasia or progression to prolactinoma
(Melmed 2003, Ben-Jonathan et al. 2008).
The current study was designed to further deﬁne the short
and longer term mitotic and apoptotic effects of continuous
oestrogen exposure on the rat anterior pituitary. We have used
both highly accurate direct histological assessment of mitotic
index and BrdU incorporation in vivo to compare baseline
anterior pituitary cell turnover and longer-term cumulative
changes in the number of dividing cells, respectively, in male
and female Wistar rats. Using an ovariectomized rat model,
we then further investigated the ability of exogenous
oestrogen to stimulate and/or sustain an increase in mitosis
in both the short term and the longer term.
Understanding the nature of pituitary mitotic and
apoptotic responses to oestrogen is important as it is
principally newly formed cells rather than mature pituitary
cells that aresensitive to trophic stimuli(Nolan et al. 1999). By
intermittently stimulating mitosis and accelerating apoptosis,
ﬂuctuating levels of oestrogen may be able to repopulate the
nascent cell compartment and potentially sensitize the
pituitary to a broad range of trophic stimuli (Aoki Mdel
et al. 2003, Nunez et al. 2003, Pisera et al. 2004, Jaita et al.
2005, Candolﬁ et al. 2006). This mechanism is likely to be at
least in part responsible for sexually dimorphic neuroendo-
crine responses such as the response to stress (Rhodes &
Rubin 1999, Sandoval et al. 2003).
Animals and treatments
All procedures were carried out in accordance with UK
Home Ofﬁce animal welfare regulations. Male and female
Wistar rats (Charles River, UK) were group housed and
allowed to acclimatize for 1 week in our animal holding
facility before the start of experimental procedures. Female
rats weighed 150–175 g and male rats weighed 100–125 g on
arrival. Groups of animals were killed by stunning and
decapitation at the time intervals described below.
In order to determine baseline cell turnover in intact,
cycling female rats, groups of animals were given a single
intraperitoneal injection of 0.5 mg/100 g body weight of
colchicine (Sigma) at time 0 h and killed 1.5, 3, 4.5o r6h
later. Control animals were given saline vehicle only and
killed at time 0 h (Nolan et al. 1999).
To follow both short- and longer-term cumulative changes
in the number of dividing anterior pituitary cells (i.e. cell
proliferation minus apoptosis of BrdU-labelled cells), groups
of intact male and female rats received either a single
intraperitoneal injection of (BrdU; 10 mg/ml in 0.007 M
NaOH/0.9% (w/v) NaCl; Roche) at a dose of 200 mg/kg
body weight at 1.5, 3, 6, 12 or 24 h prior to killing or daily
injections of BrdU for up to 14 days.
Further groups of female Wistar rats were either surgically
ovariectomized or sham operated under ﬂuorothane anaes-
thesia. For post-operative pain relief, anaesthetized rats were
given a s.c. injection (4 mg/kg body weight in a total volume
of 0.2 ml in saline) of the non-steroidal anti-inﬂammatory
Carprofen (Pﬁzer, Kent, UK). Starting 4 days after surgery,
groups of ovariectomized and sham-operated rats were given
daily s.c. injections of either oestrogen (17b-oestradiol,
E-8875 Sigma) or saline vehicle for 7 days. Oestrogen was
either given at a dose designed to approximate physiological
levels, 5 mcg/day (w23 mcg/kg per day; Sakemi et al. 1998,
Zhang et al. 2000) or at a higher, pharmacological dose of
50 mcg/day (230 mcg/kg per day). On day 11 after surgery,
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0.5 mg/100 g body weight of colchicine or saline vehicle and
killed 0, 1.5, 3, 4.5 or 6 h later.
To examine the effects of longer-term high-dose oestrogen
exposure in this model, additional groups of ovariectomized
or sham-operated rats received the same physiological and
high doses of oestrogen used above, but divided as twice
weekly s.c. injections in sesame oil for 28 days before
colchicine administration on day 32 after surgery. Vehicle-
treated rats were given sesame oil alone. As an additional
indicator of mitotic activity, 24 h before killing, some groups
of rats were also given a single intraperitoneal injection of
BrdU. Rats were weighed at this time point and pituitaries
wereweighed immediatelyafter removal before being ﬁxed in
4% formaldehyde in PBS.
Rats in the 7-day and 28-day study received the same
equivalent daily dose of 17b-oestradiol divided into the same
total number of boluses over the duration of each study.
A similar number of oestrogen injections between groups
(8 in total) was used to ensure that the effects of stresses
associated with handling and with the injections themselves
were kept as similar as possible. It was also felt to be important
to minimize the impact of a potentially high total number of
injections for animals in the 28-day study – bearing in mind
the fact that animals were also receiving relatively large
volume injections of BrdU. Our previous published (Nolan &
Levy 2006) and unpublished experience indicates that
intermittent injections of 17b-oestradiol in sesame oil vehicle
provides a very secure route to high circulating levels of
oestradiol and smooth mitotic response that does not differ if
results are assessed on the day of injection or on the days
betweeninjections.Ahighpharmacological doseofoestrogen
was used for the high-dose groups to minimize the possibility
that a higher dose might result in more persistent changes.
BrdU immunohistochemistry
Standard pituitary tissue sections for trophic analysis and
immunohistochemistry were prepared as described (Nolan
& Levy 2006). Pituitary sections were processed for BrdU
immunohistochemistry according to a previously published
protocol (Cameron & McKay 1999) with minor modiﬁ-
cations (Nolan et al. 2004). Brieﬂy, de-waxed and
rehydrated sections were transferred to a hot antigen
unmasking solution (0.01 M citric acid in water; pH 6.0)
and incubated for 10 min in a microwzing for 10 min in
0.001% trypsin (Roche) diluted in 0.1% (w/v) CaCl2/
20 mM Tris buffer (pH 7.5). Following three washes in
PBS, the sections were denatured in 2 N HCl in PBS for
30 min, washed again in PBS, gently agitated for 30 min in
blocking serum (3% (v/v) normal horse serum, 0.5% (v/v)
Triton X-100 in PBS) and incubated overnight at 4 C with
monoclonal anti-BrdU antibody (Becton Dickinson
#347580 Franklin Lakes, NJ, USA; 1/100 diluted in
blocking serum). Sections were washed in three changes
of PBS, incubated for 1 h at room temperature with
biotinylated anti-mouse IgG (Vector Labs, Peterborough,
England; 1/200 diluted in blocking serum), and washed
again in fresh PBS before blocking endogenous peroxidases
for 30 min with 0.6% (v/v) hydrogen peroxide in PBS.
Following a further three washes in PBS, sections were
incubated with RTU Vectastain Elite ABC reagent (PK-
7100; Vector Labs) for 1 h at room temperature, rinsed in
PBS and developed for w 8 min in DAB substrate
according to the manufacturer’s instructions (SK-4100;
Vector Labs). The resulting brown colour reaction was
stopped in water and the sections lightly counterstained
with hematoxylin.
Image analysis for mitotic activity
Mitotic event prevalence was analysed on 2 mm-thick
hematoxylin and eosin-stained pituitary sections at 1000!
magniﬁcation (Nolan et al. 1998) using a real-time system
(AxioHOME Zeiss, Welwyn Garden City, Hertfordshire,
England, Brugal et al. 1992) that projects an image of a
computer screen fractionally above the histological section.
Identiﬁer tags placed over manually identiﬁed cells and
trophic events remain in registration with the targets
irrespective of subsequent stage movements and magni-
ﬁcation changes. For each animal, three random areas of
w 47 000 mm
2 were scored for the presence of mitotic
ﬁgures. By deﬁning counting boundaries at low power and
counting events at high power, selection bias and double
scoring were eliminated, allowing the error in quantifying
the number of normal cells surrounding these events to be
limited to % 2% and the overall error in estimating the
prevalence of trophic events to be reduced to w0.001%.
Results were expressed as a percentage of the total cell
numbers counted for each animal.
BrdU-immunopositive cell counts were performed at
1000! magniﬁcation. For each animal, three areas totalling
0.15 mm
2 containing an average of 2000 cells were scored as
positive or negative for the presence of immunoreactive
BrdU. All slides were coded and counted by one blinded
observer (LAN) and the results expressed as the mean GS.E.M.
with differences between groups evaluated using one-way
ANOVA followed by Tukey–Kramer multiple comparison
post-tests. P!0.05 was considered statistically signiﬁcant.
Results
Pituitary cell turnover under baseline conditions in young female
rat anterior pituitary
In intact young (10 weeks) female rat pituitary glands, the
mean prevalence of mitotic ﬁgures increased from 0.08G
0.019% at baseline to 0.557G0.151% after 6 h colchicine
exposure (Fig. 1A), indicating an average parenchymal cell
turnover of 1.91% per day. Presented as a scatter plot of data
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striking variability in pituitary trophic activity, greatly in
excess of that seen in intact male rats at any age (an
approximately three fold difference in S.E.M. at the 6-hour
time point (Nolan et al. 1999)).
A direct comparison between gross mitotic rate measured
using colchicine-induced mitotic arrest over 6 h and net
trophic activity (mitosis minusapoptosis over time) within the
anterior pituitary of male and female rats was made using
cumulative BrdU-labelling index measured over both the ﬁrst
24-h period of BrdU exposure and over an extended 14-day
period. Individual BrdU-labelling indices measured over the
ﬁrst 24-h period were much more variable in female than
male rats (Fig. 2A and B) in keeping with the 6-hour data
presented after colchicine treatment. In terms of net trophic
activity, which is mitosis minus apoptosis of nascent cells over
the following 14 days, however, there was no overall
difference (Fig. 2C). This suggests that recurrent waves of
increased mitotic activityare interspersed with periods of very
little mitotic activity, although the possibility that increased
mitotic activity occurs concurrently with increased apoptotic
activity, and vice versa, although unlikely, cannot be
conﬁdently excluded from these data.
Acute oestrogen exposure increases pituitary cell turnover in
female rats
Female rats were either ovariectomized or sham-operated and
left to recover for 4 days before being treated with daily
injections of oestrogen or vehicle for the next 7 days.
Figure 2 Cumulative increase in bromodeoxyuridine (BrdU)
immunopositive cells as a percentage of total parenchymal cells
inintact(A) female(B)andmaleWistarratsduringtheﬁrst24 hafter
a single BrdU injection. Data points are shown for each individual
animal together with means. nZ3–6 at all time points. (C) Com-
parison of the cumulative increases in BrdU immunopositive cells
in male and female rats receiving daily injections of BrdU for up to
14 days. MeansGS.E.M.s are shown; nZ3–7 at all time points.
Figure 1 Changes in the prevalence of mitotic ﬁgures with time in
intact female rats given a single intraperitoneal injection of
colchicine. (A) Mean values with 95% conﬁdence limit lines (upper
panel) and (B) A scatter plot of values obtained from individual rats
(lower panel). nZ11–12 at all time points.
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Insham-operatedratsreceivingvehicleonly,i.e.exposedto
endogenous oestrogen dictated by the normal oestrous cycle,
themeanprevalenceofmitoticﬁguresincreasedfrom0.121G
0.028% at baseline to 0.699G0.272% after 6 h colchicine
exposure representing a cell turnover of 2.31% per day
(Fig. 3A). These data conﬁrmed the variability in baseline cell
turnover previously observed in cycling female rats.
In ovariectomized rats in the absence of oestrogen
replacement, the mean prevalence of mitotic ﬁgures increased
from 0.122G0.027% at baseline to 0.548G0.107% after 6 h
representingaslightlydecreasedcellturnoverof1.70%perday
(Fig. 3B). Removal of oestrogen, for 4 days at least, decreased
but did not completely abolish the variability of cell turnover
between individual animals seen in females but not males.
In ovariectomized rats receiving daily injections of
oestrogen to approximate circulating physiological levels, the
mean prevalence of mitotic ﬁgures increased from 0.172G
0.031% at baseline to 0.945G0.119% after 6 h representing a
small increase in cell turnover to 3.09% per day at the lower
dose of exogenous oestrogen (Fig. 3C). The mean prevalence
of mitotic ﬁgures increased from 0.21G0.033% at baseline
to 1.145G0.19% after 6 h representing a greater increase in
cell turnover to 3.74% per day when the rats received
a pharmacological dose of exogenous oestrogen (Fig. 3D).
Using direct morphological identiﬁcation of apoptotic
bodies in H&E-stained tissue sections, there were no
measurable differences in the very low apoptotic indices
between any of the experimental groups at baseline, i.e. prior
to colchicine exposure (Fig. 4). After 6 h of colchicine
treatment however, there was a measurable increase in the
mean apoptotic index in rats that had been exposed to
oestrogen that reached statistical signiﬁcance in the ovari-
ectomized animals treated with the physiological dose of
oestrogen (Fig. 4).
An increase in mitotic index is not sustained during longer-term
oestrogen exposure
The mean body weight of ovariectomized rats not
supplemented with oestrogen was signiﬁcantly higher than
that of intact cycling animals after 28 days and signiﬁcantly
lower in ovariectomized rats given the highest dose of
oestrogen (Fig. 5A; Bryzgalova et al. 2008). Pituitary wet
weight was signiﬁcantly increased in ovariectomized rats
treated with the higher dose of oestrogen (Fig. 5B).
Contrary to expectations, the increases in mitotic index
seen after 7 days of oestrogen treatment were not sustained
after 28 days of oestrogen treatment and at this time there
were no signiﬁcant differences in the cumulative mitotic
indices measured after colchicine-induced metaphase arrest
(Fig. 6).
These data were conﬁrmed by the signiﬁcant reduction of
BrdU-labelled cells following a 24-hour exposure immedi-
ately prior to killing at 28 days compared with that found at
Figure 3 Comparison of the prevalence of mitotic ﬁgures with time
in rats given a single intraperitoneal injection of colchicine 7 days
after the start of oestrogen or vehicle treatment. (A) Control, sham-
operated-vehicle treated rats; (B) ovariectomized-vehicle treated
rats; (C) ovariectomized rats receiving physiological oestrogen
replacement injections and (D) ovariectomized rats receiving high-
dose oestrogen injections. Mean values with 95% conﬁdence limit
lines are shown. nZ4–6 at all time points.
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in ovariectomized rats treated with vehicle is presumably due
to a period of time in excess of 7 days required to stabilize
anterior pituitary proliferation following withdrawal of
endogenous oestrogen at the time of surgery.
Discussion
Histologically, the adult anterior pituitary appears to be
relatively trophically quiescent in comparison with many
other tissues. However, the pars distalis is not only mitotically
active under basal conditions but has been shown to be highly
responsive to changes in ambient glucocorticoid, male
Figure 4 Comparison of the prevalence of apoptotic ﬁgures with
time in rats given a single intraperitoneal injection of colchicine
7 days after the start of oestrogen or vehicle treatment. (A) Control,
sham-operated-vehicle treated rats; (B) ovariectomized-vehicle
treated rats; (C) ovariectomized rats receiving physiological
oestrogen replacement injections and (D) ovariectomized rats
receiving high-dose oestrogen injections. Mean values with the
scatter of individual data points are shown. nZ4–6 at all time
points. *P!0.05 compared with all other time points.
Figure 5 The effects of ovariectomy (ovx) and/or oestrogen
treatments (Es) on (A) total body weight and (B) pituitary wet
weight 28 days after the start of oestrogen or vehicle treatment.
MeansGS.E.M.s are shown; nZ27–30; ***P!0.001 and NS not
signiﬁcant, compared with sham-operated, vehicle-treated
controls.
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1999, 2004). Several studies have also been sensitive enough
to suggest a diurnal variation in mitotic activity in the
pituitary, although there is some disagreement about the exact
number and timing of peak/s and nadirs (Nouet & Kujas
1975, Carbajo-Perez & Watanabe 1990, Carbajo-Perez et al.
1991, Oishi et al. 1993, McNicol & Carbajo-Perez 1999; for
review (Levy 2002). The control of trophic activity in the
pituitary and other endocrine organs is of particular interest
because of the high prevalence and unusual behaviour of
nodule and adenoma formation in these tissues. After
induction and an initial period of growth, net cell turnover
in these trophic anomalies returns to normal in almost all
cases. They subsequently remain static from a net trophic
point of view for long periods of time or even, occasionally,
resolve of their own accord. Progressive growth, whilst
familiar in the clinical setting, is numerically relatively
unusual. Nevertheless, the modest increase in size of the
pituitary in females compared with males and in parous
compared with nulliparous females, and the dramatic trophic
effects of high-dose oestrogen exposure in some rat strains
such as the Fischer 344 (Shull et al. 1998), has led to the belief
that oestrogen is not only a powerful pituitary mitogen, but
that its effects are also particularly persistent.
In the present study, the observation of sexually dimorphic
pituitary mitotic activity with increased individual variability
of pituitary mitotic activity in intact female rats strongly
implicates ﬂuctuating oestrogen levels associated with the
oestrous cycle in rapid changes in pituitary mitotic activity.
However, administration of daily BrdU injections over a
14-day period, which permitted analysis of cumulative
mitotic activity in Wistar rats, showed that there was
absolutely no evidence of a sex difference in net mitotic
activity after the ﬁrst 24 h. This ﬁnding may contrast with the
ﬁndings of one other group who examined Sprague–Dawley
rats and found ‘cumulative incorporation of BrdU in females
to be consistently twice as high as in males’ but nevertheless
concluded that ‘cell renewal occurs at a doubled rate in the
pituitary of female rats’ (Oishi et al. 1993), implying once
again that there may be a relationship with cell turnover but
without a net gain in comparison with males.
Exogenousoestrogengiventointact,youngmaleratsresults
in an increase in mitotic activity that peaks after 3 days and
appears to drift back towards baseline by 7 days despite
continuing exposure without any evidence of a concurrent
Figure 6 Lack of effect of sustained oestrogen treatment on the
prevalence of mitotic ﬁgures with time in rats given a single
intraperitoneal injection of colchicines 28 days after the start of
oestrogen or vehicle treatment. (A) Control, sham-operated-vehicle
treated rats; (B) ovariectomized-vehicle treated rats; (C) ovari-
ectomized rats receiving physiological oestrogen replacement
injections and (D) ovariectomized rats receiving high-dose
oestrogen injections. Mean values with 95% conﬁdence limit lines
are shown. nZ4–6 at all time points.
Figure 7 The prevalence of bromodeoxyuridine (BrdU) immuno-
positive cells as a percentage of total parenchymal cells in
ovariectomized (Ovx) or sham-operated rats treated with oestrogen
or vehicle for 7 days (open bars) and 28 days (grey bars). BrdU was
given for 24 h before killing in all groups. MeansGS.E.M.s are
shown; nZ4–7; *P!0.05, **P!0.01 and ***P!0.001 compared
with the 7-day treatment point. NS not signiﬁcant.
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of apoptoticbodies(Nolan&Levy2006).Inthepresentstudy,
7 days after the start of oestrogen treatment in ovariectomized
rats, weobserved asigniﬁcant, dose-dependent increase in cell
proliferation measured by colchicine-induced metaphase
arrest. After 28 days of continuous exogenous oestrogen
exposure at physiological or supra-physiological levels,
anterior pituitary mitotic rate was indistinguishable from that
found in either sham-operated cycling rats or ovariectomized
ratsreceivingvehiclealone,despiteanincreaseinpituitarywet
weight over that period. The exact timing of oestrogen
injection did not affect the mitotic or apoptotic indices
measured as no differences were found when the last dose of
oestrogen was given either 3 days or 1 day prior to the
administration of colchicine (data not shown).
The self-limiting nature of longer term mitotic and
apoptotic responses to persistent stimuli is a consistent
characteristic of pituitary trophic activity and may be related
to receptor down-regulation (Shupnik 2002) or differential
modulation of downstream co-activators or repressors and/or
autocrine/paracrine growth factors such as galanin, trans-
forming growth factor a (TGFa) and TGFb (Chun et al.
1998, Denef 2003). Sudden changes rather than persistent
hormonal abnormalities appear to be the key to induction of
pituitary trophic activity. Certainly, exposure to oestrogen for
28 days results in a signiﬁcant increase in pituitary wet weight
in both female (Fig. 5B) and male Wistar rats (our own
unpublished data). This does not, however, correlate
necessarily with an increase in total pituitary cell number,
which might be accounted for by increased cell size, increased
vascularity and decreased apoptosis of post-mitotic cells.
It has been suggested that peaks of circulating oestrogen
might sensitize pituitary cells to pro-apoptotic signals such as
lipopolysaccharide, FasL and dopamine (Pisera et al. 2004,
Jaita et al. 2005, Radl et al. 2008). Induction of apoptosis is
frequently mediated through the Fas/FasL system during
physiological cell turnover in cycling hormone-dependent
tissues. Both the Fas receptor and ligand are expressed in
lactotrophs and although apoptosis in these cells has been
shown in some studies to be enhanced byoestrogen (Jaita et al.
2005), others have suggested that the cells that undergo
cyclical apoptotic changes during the oestrous cycle are
mainly gonadotrophs and that there is no direct effect of
oestrogen involved (Yin & Arita 2002).
After 6 h of colchicine treatment, there was an increase in
the mean prevalence of apoptotic cells in both sham-operated
intact rats and ovariectomized rats treated with oestrogen at
both endpoints. In the absence of oestrogen, there was no
measurable increase in apoptosis, suggesting that oestrogen
can sensitize a small population of anterior pituitary cells to
the pro-apoptotic effects of colchicine. The signiﬁcance of
this ﬁnding is unclear. We did not detect any signiﬁcant
differences in the very low baseline prevalence of apoptotic
events following oestrogen treatment for either 7 or 28 days,
but it is important to point out that at these very low levels
small changes, with potentially very considerable biological
signiﬁcance, are likely to have been undetectable. Unfortu-
nately, in our experience, histological methods with
potentially greater sensitivity than direct morphological
identiﬁcation but relatively low speciﬁcity such as TUNEL
and caspase-3 immunocytochemistryare non-contributory in
these circumstances.
In summary, oestrogen is believed to exert powerful trophic
effects on the pituitary. It is thought to be responsible for the
increase in pituitary size during pregnancy in humans, and to
lead to dramatic pituitary hyperplasia and adenoma formation
in some strains of rat. This study was designed to quantify
these potent and persistent trophic effects of oestrogen. In
complete contrast to expectations, continuous exposure to
high-dose oestrogen for 28 days resulted in a return of
anterior pituitary mitotic activity to baseline. In female Wistar
rats at least, high-dose oestrogen is not sufﬁcient to induce
persistent pituitary mitotic activity.
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